Masaki Terabe,
Jay A. Berzofsky
Springer New York
2012e druk, 2011
9781461406129
Natural Killer T cells
Balancing the Regulation of Tumor Immunity
Specificaties
Gebonden, 208 blz.
|
Engels
Springer New York |
2012e druk, 2011
ISBN13: 9781461406129
Rubricering
Onderdeel van serie
Cancer Drug Discovery and Development
Levertijd ongeveer 8 werkdagen
Samenvatting
This book will cover primary roles of NKT cells in immunity to cancer, in both mouse tumor models and cancer patients. There are several chapters describing general aspects of NKT cells.
Specificaties
ISBN13:9781461406129
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:208
Uitgever:Springer New York
Druk:2012
Inhoudsopgave
<p>Preface.- Introduction: Mechanisms of NKT cell-mediated adjuvant activity and function of iPS-derived NKT cells.- Structure and Recognition of Antigens for Invariant NKT Cells.- Invariant NKT cell-based vaccine strategies.- Immune regulation of tumor immunity by NKT cells.- The Regulation of CD1d<sup>+</sup> and CD1d<sup>-</sup> tumors by NKT Cells.- DC-based immunotherapy targeting NKT cells.- Therapeutic Approaches Utilising NKT Cells.- NKT Cells of Cancer Patients & How Models can Inform Therapeutic Plans.- Understanding the role of Natural Killer T (NKT) cells in hematologic malignancies: progress and challenges.- Clinical trials with α-galactosylceramide (KRN7000) in advanced cancer.- Clinical trials of invariant Natural Killer T cell-based immunotherapy for cancer.- Index. </p>